Dr. John Streiff is chief scientific officer and lead chemist for InflammaNova Rx (INRx), LLC. Prior to co-founding INRx with Dr. Lisa Schwiebert, Dr. Streiff served as a chief cheminformatics officer for other small biotech companies in the Birmingham, AL area for approximately 20 years. In this role, he was responsible for automating high-throughput screening assays and maintaining libraries of small molecule. As principal investigator for this MJFF-sponsored project, Dr. Streiff will lead the experimental design and data interpretation in the areas of medicinal, computational and digital chemistry. In addition, he will work with Dr. Lisa Schwiebert on communicating with the various contact research organizations and academic collaborators.
Associated Grants
-
Therapeutic Development of Novel STING Inhibitors to Treat Parkinson's Disease Neuroinflammation
2024